In response to a growing consumer interest, the companies have decided to jointly develop innovative probiotic products with documented health benefits. The cooperation will initially focus on oral health.
Probi is an expert in research, development and manufacturing of probiotics. Probi’s probiotics are included in some of the most effective products for gut and immune health currently available on the global market. Expanding into new areas such as oral health will offer additional growth potential for the company.
Dr Heinz-Jürgen Bertram, president of Symrise, said: “This partnership is a logical result of the growing demand for consumer products with documented health benefits. Our complementary expertise and strategic agendas in innovation will allow us to better support our customers in their development and marketing.”
Symrise AG currently owns 14.97 % of the shares in Probi.
Source: Symrise
© FoodBev Media Ltd 2024